Inventor · disambiguated record
Carlo Boutton
Also filed as: BOUTTON CARLO · BOUTTON CARLO WILLY MAURICE
37 granted patents·19 pending applications·261 citations·filing 2000–2024
97Inventor score
Files withABLYNX NV35MERCK SHARP & DOHME6DESMET JOHAN3REVETS HILDE ADI PIERRETTE3MERCK SHARP & DOHME LLC2
Top patents by PatentIndex Score
56 records- 0199US11485777B2Immunoglobulin variable domainsABLYNX NV·Filed 2021·Granted Nov 1, 2022·8 cites·16 claims
- 0299US11485778B2Immunoglobulin variable domainsABLYNX NV·Filed 2021·Granted Nov 1, 2022·7 cites·10 claims
- 0399US11319364B2Immunoglobulin variable domainsABLYNX NV·Filed 2021·Granted May 3, 2022·8 cites·13 claims
- 0499US11312765B2Immunoglobulin variable domainsABLYNX NV·Filed 2021·Granted Apr 26, 2022·9 cites·15 claims
- 0599US11220539B2Immunoglobulin variable domainsABLYNX NV·Filed 2020·Granted Jan 11, 2022·9 cites·23 claims
- 0698US11708404B2Immunoglobulin variable domainsABLYNX NV·Filed 2022·Granted Jul 25, 2023·4 cites·14 claims
- 0797US11312764B2Immunoglobulin variable domainsABLYNX NV·Filed 2019·Granted Apr 26, 2022·10 cites·19 claims
- 0897US10858418B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Dec 8, 2020·18 cites·20 claims
- 0996US10323090B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2016·Granted Jun 18, 2019·26 cites·31 claims
- 1095US8975382B2Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumorsREVETS HILDE ADI PIERRETTE·Filed 2008·Granted Mar 10, 2015·42 cites·16 claims
- 1194US11426468B2Cysteine linked nanobody dimersABLYNX NV·Filed 2015·Granted Aug 30, 2022·14 cites·6 claims
- 1293US10544222B2PD1/CTLA4 bindersMERCK SHARP & DOHME·Filed 2016·Granted Jan 28, 2020·22 cites·15 claims
- 1393US10501542B2CTLA4 bindersMERCK SHARP & DOHME·Filed 2016·Granted Dec 10, 2019·16 cites·15 claims
- 1492US11192937B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·6 claims
- 1592US11192938B2Serum albumin binding proteins containing immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·35 claims
- 1691US11155619B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2019·Granted Oct 26, 2021·4 cites·8 claims
- 1791US9969805B2Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumorsABLYNX NV·Filed 2015·Granted May 15, 2018·10 cites·20 claims
- 1888US12180268B2Immunoglobulin variable domainsABLYNX NV·Filed 2015·Granted Dec 31, 2024·2 cites·10 claims
- 1988US8217140B2Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the sameREVETS HILDE ADI PIERRETTE·Filed 2009·Granted Jul 10, 2012·11 cites·18 claims
- 2087US11932702B2Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and T cell receptorABLYNX NV·Filed 2021·Granted Mar 19, 2024·3 cites·28 claims
- 2187US11168136B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2019·Granted Nov 9, 2021·2 cites·18 claims
- 2287US11168135B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME·Filed 2019·Granted Nov 9, 2021·2 cites·16 claims
- 2387US9328174B2Chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2013·Granted May 3, 2016·8 cites·11 claims
- 2485US12006352B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Jun 11, 2024·1 cites·6 claims
- 2585US11021544B2Nanobody dimers linked via C-terminally engineered cysteinsABLYNX NV·Filed 2016·Granted Jun 1, 2021·4 cites·21 claims
- 2685US2023242620A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2023·Application pending·0 cites
- 2783US11306139B2Glycosylated immunoglobulin single variable domainsABLYNX NV·Filed 2016·Granted Apr 19, 2022·2 cites·24 claims
- 2883US2022332806A1Immunoglobulin variable domainsABLYNX NV·Filed 2022·Application pending·0 cites
- 2983US2022332807A1Immunoglobulin variable domainsABLYNX NV·Filed 2022·Application pending·0 cites
- 3081US11644471B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2013·Granted May 9, 2023·2 cites·9 claims
- 3179US12351630B2PD1 and/or LAG3 bindersMERCK SHARP & DOHME LLC·Filed 2021·Granted Jul 8, 2025·0 cites·7 claims
- 3279US11649290B2CTLA4 bindersMERCK SHARP & DOHME LLC·Filed 2019·Granted May 16, 2023·1 cites·14 claims
- 3379US8571806B2Method for generating information related to the molecular structure of a biomoleculeDESMET JOHAN·Filed 2010·Granted Oct 29, 2013·3 cites·42 claims
- 3472US8229721B1Apparatus and method for structure-based prediction of amino acid sequencesDESMET JOHAN·Filed 2000·Granted Jul 24, 2012·2 cites·13 claims
- 3571US9688763B2Chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2015·Granted Jun 27, 2017·1 cites·10 claims
- 3669US12384835B2Cysteine linked nanobody dimersABLYNX NV·Filed 2022·Granted Aug 12, 2025·0 cites·19 claims
- 3768US2022324951A1Glycosylated immunoglobulin single variable domainsABLYNX NV·Filed 2022·Application pending·0 cites
- 3868US2024368250A1Polypeptides binding to the neonatal fc receptorABLYNX NV·Filed 2024·Application pending·0 cites
- 3966USRE50682EImmunoglobulin variable domainsABLYNX NV·Filed 2022·Granted Dec 2, 2025·0 cites·19 claims
- 4066US2018355031A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2018·Application pending·0 cites
- 4166US2024343823A1Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and t cell receptorABLYNX NV·Filed 2024·Application pending·0 cites
- 4266US2024132624A1Polypeptides binding to a specific epitope of the neonatal fc receptorABLYNX NV·Filed 2023·Application pending·0 cites
- 4365US2025296991A1Precision activated polypeptidesABLYNX NV·Filed 2024·Application pending·0 cites
- 4462US2018009888A9Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsBAUMEISTER JUDITH·Filed 2012·Application pending·0 cites
- 4562US2013211808A2Apparatus and method for structure-based prediction of amino acid sequencesDESMET JOHAN·Filed 2012·Application pending·0 cites
- 4661US2024415974A1Protein-based conjugation carriersABLYNX NV·Filed 2023·Application pending·0 cites
- 4755US2011245463A1Apparatus and method for structure-based prediction of amino acid sequencesALGONOMICS N V·Filed 2011·Application pending·0 cites
- 4854US11466089B2Chemokine receptor binding polypeptidesABLYNX NV·Filed 2017·Granted Oct 11, 2022·0 cites·10 claims
- 4952US2011091462A1Novel antigen binding dimer-complexes, methods of making and uses thereofABLYNX NV·Filed 2009·Application pending·0 cites
- 5050US2012253008A1Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the sameREVETS HILDE ADI PIERRETTE·Filed 2012·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →